A 54-year-old man with long-standing type 2 diabetes attends annual review. His HbA1c is 70 mmol/mol (8.6%) despite maximum tolerated Metformin. He is overweight, with no established CVD and wishes to avoid weight gain. According to NICE type 2 diabetes guidance, which additional agent would be most appropriate?